Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3A | P31941 | 1/20 | 0.33 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29721906 | 1.00 | APOBEC3A (0.33) | APOBEC3AAPOBEC3GHTTKDM4ESMN1; SMN2 | |
| SCHEMBL21614534 | 1.00 | APOBEC3A (0.33) | APOBEC3AAPOBEC3GHTTKDM4ESMN1; SMN2 | |
| SCHEMBL21614505 | 0.83 | CHRM2 (0.34) | — | |
| SCHEMBL21614531 | 0.83 | CHRM2 (0.34) | — | |
| SCHEMBL28543298 | 0.79 | HRH3 (0.37) | APOBEC3AAPOBEC3GHTTKDM4ESMN1; SMN2 | |
| SCHEMBL21614546 | 0.79 | HRH3 (0.37) | APOBEC3AAPOBEC3GHTTKDM4ESMN1; SMN2 | |
| SCHEMBL21611842 | 0.79 | HRH3 (0.37) | APOBEC3AAPOBEC3GHTTKDM4ESMN1; SMN2 | |
| SCHEMBL24183731 | 0.79 | CHRM2 (0.37) | — | |
| SCHEMBL21614537 | 0.79 | CHRM2 (0.37) | — | |
| SCHEMBL21614517 | 0.79 | CHRM2 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3818047-B1 | NOVEL COMPOUNDS FOR CONTROLLING ARTHROPODS | BAYER ANIMAL HEALTH GMBH (DE) | 2022-07-27 | — | — | EP | disclosed |
| US-11357755-B2 | Compounds for controlling arthropods | BAYER ANIMAL HEALTH GMBH (DE) | 2022-06-14 | — | — | US | disclosed |
| US-11357755-B2 | Compounds for controlling arthropods | BAYER ANIMAL HEALTH GMBH (DE) | 2022-06-14 | — | — | US | disclosed |
| US-20220008391-A1 | NOVEL COMPOUNDS FOR CONTROLLING ARTHROPODS | BAYER ANIMAL HEALTH GMBH (DE) | 2022-01-13 | — | — | US | disclosed |
| WO-2020007704-A1 | NOVEL COMPOUNDS FOR CONTROLLING ARTHROPODS | BAYER ANIMAL HEALTH GMBH (DE) | 2020-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220008391-A1 | NOVEL COMPOUNDS FOR CONTROLLING ARTHROPODS | DDT, AAAS, AGO2 | APOBEC3A 1587/4885APOBEC3G 1626/4885HTT 1659/4885 |
| US-11357755-B2 | Compounds for controlling arthropods | DDT, AAAS, AGO2 | APOBEC3A 632/4885APOBEC3G 641/4885HTT 1208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.